Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection

被引:32
作者
Lewis-Ximenez, LL
Oliveira, JM
Mercadante, LAC
De Castro, L
Santa Catharina, W
Stuver, S
Yoshida, CFT
机构
[1] FIOCRUZ, Inst Oswaldo Cruz, Dept Virol, BR-21045900 Rio De Janeiro, Brazil
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Inst Doencas Renais, Sao Paulo, Brazil
来源
NEPHRON | 2001年 / 87卷 / 01期
关键词
hepatitis B virus; outbreak; hemodialysis unit; vaccination; Brazil;
D O I
10.1159/000045880
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
During an outbreak of hepatitis B virus (HBV) infection in a hemodialysis unit, patients were assessed for serological viral markers and vaccination status. HBV infection was identified in 26 patients. Twenty of these were positive for hepatitis B surface antigen (HBsAg), and 6 were negative for HBsAg but positive for IgM antibody to hepatitis B core (anti-HBc) and HBV DNA. The primary source of infection was not clearly identified, although 2 patients were suspected to be the index cases. A multiple logistic regression analysis revealed low anti-HBs titers and vaccination status to be independently associated with the risk of acquiring HBV infection. Both the high prevalence of HBV infection (31%) detected in this unit and the low vaccine response (53%) observed reinforce the importance of universal and preventive measures in controlling HBV infection. The detection of HBV DNA in HBsAg-negative/IgM anti-HBc-positive patients emphasizes the value of anti-HBc testing in the routine screening of HBV in hemodialysis units. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 30 条
[1]   IMPACT OF INFECTION CONTROL STRATEGIES ON THE INCIDENCE OF DIALYSIS-ASSOCIATED HEPATITIS IN THE UNITED-STATES [J].
ALTER, MJ ;
FAVERO, MS ;
MAYNARD, JE .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (06) :1149-1151
[2]   HEPATITIS-B VIRUS-DNA IN PATIENTS WITH CHRONIC LIVER-DISEASE AND NEGATIVE TESTS FOR HEPATITIS-B SURFACE-ANTIGEN [J].
BRECHOT, C ;
DEGOS, F ;
LUGASSY, C ;
THIERS, V ;
ZAFRANI, S ;
FRANCO, D ;
BISMUTH, H ;
TREPO, C ;
BENHAMOU, JP ;
WANDS, J ;
ISSELBACHER, K ;
TIOLLAIS, P ;
BERTHELOT, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (05) :270-276
[3]   EFFECTS OF DIFFERENT DOSE LEVELS AND VACCINATION SCHEDULES ON IMMUNE-RESPONSE TO A RECOMBINANT DNA HEPATITIS-B VACCINE IN HEMODIALYSIS-PATIENTS [J].
BRUGUERA, M ;
RODICIO, JL ;
ALCAZAR, JM ;
OLIVER, A ;
DELRIO, G ;
ESTEBANMUR, R .
VACCINE, 1990, 8 :S47-S49
[4]  
Cabrerizo M, 1997, J AM SOC NEPHROL, V8, P1443
[5]   VIRAL GENETIC-VARIATION - HEPATITIS-B VIRUS AS A CLINICAL EXAMPLE [J].
CARMAN, W ;
THOMAS, H ;
DOMINGO, E .
LANCET, 1993, 341 (8841) :349-353
[6]  
*CDC, 1996, MMWR-MORBID MORTAL W, V45, P285
[7]   Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection [J].
Cheng, CH ;
Huang, CC ;
Leu, ML ;
Chiang, CYF ;
Wu, MS ;
Lai, PC .
VACCINE, 1997, 15 (12-13) :1353-1357
[8]   COMPARISON OF 2 IMMUNIZATION SCHEDULES WITH RECOMBINANT HEPATITIS-B VACCINE AND NATURAL IMMUNITY ACQUIRED BY HEPATITIS-B INFECTION IN DIALYSIS PATIENTS [J].
ELRESHAID, K ;
ALMUFTI, S ;
JOHNY, KV ;
SUGATHAN, TN .
VACCINE, 1994, 12 (03) :223-228
[9]  
GASPAR A M C, 1987, Memorias do Instituto Oswaldo Cruz, V82, P253, DOI 10.1590/S0074-02761987000200013
[10]   DIAGNOSIS OF ACUTE AND INAPPARENT HEPATITIS-B VIRUS-INFECTIONS BY MEASUREMENT OF IGM ANTIBODY TO HEPATITIS-B CORE ANTIGEN [J].
GERLICH, WH ;
LUER, W ;
THOMSSEN, R .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (01) :95-101